David Dean

Cormark Securities Inc. (Cormark) is an independent investment dealer headquartered in Toronto, Canada with additional office in Calgary. The firm was founded in 1981 as Sprott Securities, Inc. Cormark Securities provides execution and comprehensive coverage of Canadian listed companies to domestic and international institutional investors. They focus on Canadian-listed, mid-cap and emerging growth companies.

Versant Partners, Inc. is a broker/dealer headquartered in Montreal with additional offices in Toronto and Calgary. The firm offers a full array of investment services to institutional money managers and Canadian growth companies. They cover the aerospace, biotechnology, electronics manufacturing, communications equipment and services sectors. Within those sectors, Versant Partners focuses primarily on small- and mid-sized companies. The firm executes trades on all major North American stock exchanges. They are a member of the Canadian Investor Protection Fund.

Yorkton Securities, Inc. is a private company based in Vancouver, CA. and has subsidiaries in United States. The Canadian company provides security brokerage services.

Cantor Fitzgerald Canada Corp. (CFCC) is a broker/dealer located in Toronto, Ontario. The firm is a subsidiary of Cantor Fitzgerald LP and their ultimate parent is CF Group Management, Inc. They offer clients an array of financial products and services in the equity and fixed-income capital markets. CFCC provides sales and trading, investment banking, asset management, market commentary and market data.

National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON.

Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.